Abstract

Timely monitoring and control of critical process parameters and product attributes are still the basic tasks in bioprocess development. The current trend of automation and digitization in bioprocess technology targets an improvement of these tasks by reducing human error and increasing through-put. The gaps in such automation procedures are still the sampling procedure, sample preparation, sample transfer to analyzers, and the alignment of process and sample data. In this study, an automated sampling system and the respective data management software were evaluated for system performance; applicability with HPLC for measurement of vitamins, product and amino acids; and applicability with a biochemical analyzer. The focus was especially directed towards the adaptation and assessment of an appropriate amino acid method, as these substances are critical in cell culture processes. Application of automated sampling in a CHO fed-batch revealed its potential with regard to data evaluation. The higher sampling frequency compared to manual sampling increases the generated information content, which allows easier interpretation of the metabolism, extraction of e.g., ks values, application of smoothing algorithms, and more accurate detection of process events. A comparison with sensor technology shows the advantages and disadvantages in terms of measurement errors and measurement frequency.

Highlights

  • The performance of even complex bioprocesses depends on their control

  • For example, complex expression systems such as Chinese hamster ovary (CHO) cells are widely used for the production of biopharmaceuticals

  • The derivatization protocol had to be implemented for in-well derivatization by user defined programming (UDP)

Read more

Summary

Introduction

The performance of even complex bioprocesses depends on their control. The bottleneck is how and if relevant process variables can be monitored. For example, complex expression systems such as Chinese hamster ovary (CHO) cells are widely used for the production of biopharmaceuticals. These processes are very sensitive to small variations caused by known and unknown disturbances such as raw material, process, and biological variances. In order to ensure acceptable reliable process performance, powerful monitoring is the key [1]. The often very low concentration of the analytes may be a challenge or even an exclusion criterion for established monitoring technologies [2]

Objectives
Methods
Findings
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.